443 related articles for article (PubMed ID: 10533864)
41. Rapid detection of mutations in the human-derived Pneumocystis carinii dihydropteroate synthase gene associated with sulfa resistance.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2001 Mar; 45(3):776-80. PubMed ID: 11181359
[TBL] [Abstract][Full Text] [Related]
42. Sulfa resistance and dihydropteroate synthase mutants in recurrent Pneumocystis carinii pneumonia.
Nahimana A; Rabodonirina M; Helweg-Larsen J; Meneau I; Francioli P; Bille J; Hauser PM
Emerg Infect Dis; 2003 Jul; 9(7):864-7. PubMed ID: 12890330
[TBL] [Abstract][Full Text] [Related]
43. Detection of Pneumocystis jirovecii dihydropteroate synthase polymorphisms in patients with Pneumocystis pneumonia.
Costa MC; Gaspar J; Mansinho K; Esteves F; Antunes F; Matos O
Scand J Infect Dis; 2005; 37(10):766-71. PubMed ID: 16191898
[TBL] [Abstract][Full Text] [Related]
44. Pneumocystis prophylaxis and survival in patients with advanced human immunodeficiency virus infection treated with zidovudine. The Zidovudine Epidemiology Group.
Chaisson RE; Keruly J; Richman DD; Moore RD
Arch Intern Med; 1992 Oct; 152(10):2009-13. PubMed ID: 1417373
[TBL] [Abstract][Full Text] [Related]
45. A novel droplet digital polymerase chain reaction for diagnosis of Pneumocystis pneumonia (PCP)-a clinical performance study and survey of sulfamethoxazole-trimethoprim resistant mutations.
Jitmuang A; Nititammaluk A; Boonsong T; Sarasombath PT; Sompradeekul S; Chayakulkeeree M
J Infect; 2021 Dec; 83(6):701-708. PubMed ID: 34562541
[TBL] [Abstract][Full Text] [Related]
46. Molecular Analysis of Dihydropteroate Synthase Gene Mutations in
Tsvetkova N; Harizanov R; Rainova I; Ivanova A; Yancheva-Petrova N
Int J Mol Sci; 2023 Nov; 24(23):. PubMed ID: 38069248
[No Abstract] [Full Text] [Related]
47. Dihydropteroate synthase gene mutations in Pneumocystis jiroveci strains isolated from immunocompromised patients.
Jarboui MA; Sellami A; Sellami H; Cheikhrouhou F; Makni F; Ayadi A
Pathol Biol (Paris); 2011 Aug; 59(4):222-5. PubMed ID: 20346596
[TBL] [Abstract][Full Text] [Related]
48. Drug-resistant Pneumocystis carinii.
Meshnick SR
Lancet; 1999 Oct; 354(9187):1318-9. PubMed ID: 10533856
[No Abstract] [Full Text] [Related]
49. DHPS-mutated isolates of Pneumocystis jirovecii from HIV-infected individuals: analysis of related ITS genotypes.
Valerio A; Tronconi E; Mazza F; Cargnel A; Fantoni G; Atzori C
J Eukaryot Microbiol; 2006; 53 Suppl 1():S108-9. PubMed ID: 17169019
[No Abstract] [Full Text] [Related]
50. Absence of dihydropteroate synthase gene mutations in Pneumocystis jirovecii isolated from Swedish patients.
Beser J; Dini L; Botero-Kleiven S; Krabbe M; Lindh J; Hagblom P
Med Mycol; 2012 Apr; 50(3):320-3. PubMed ID: 21732748
[TBL] [Abstract][Full Text] [Related]
51. Absence of mutations associated with sulfa resistance in Pneumocystis carinii dihydropteroate synthase gene from non-human primates.
Demanche C; Guillot J; Berthelemy M; Petitt T; Roux P; Wakefield AE
Med Mycol; 2002 Jun; 40(3):315-8. PubMed ID: 12146763
[TBL] [Abstract][Full Text] [Related]
52. Evaluation of the PneumoGenius® PCR assay for the diagnosis of Pneumocystis pneumonia and the detection of Pneumocystis dihydropteroate synthase mutations in respiratory samples.
Guegan H; Roojee M; Le Gal S; Artus M; Nevez G; Gangneux JP; Robert-Gangneux F
Med Mycol; 2023 Apr; 61(4):. PubMed ID: 37028929
[TBL] [Abstract][Full Text] [Related]
53. Genetic analysis of multiple loci suggests that mutations in the Pneumocystis carinii f. sp. hominis dihydropteroate synthase gene arose independently in multiple strains.
Ma L; Kovacs JA
Antimicrob Agents Chemother; 2001 Nov; 45(11):3213-5. PubMed ID: 11600382
[TBL] [Abstract][Full Text] [Related]
54. Pneumocystis jirovecii genotype associated with increased death rate of HIV-infected patients with pneumonia.
Rabodonirina M; Vaillant L; Taffé P; Nahimana A; Gillibert RP; Vanhems P; Hauser PM
Emerg Infect Dis; 2013 Jan; 19(1):21-8; quiz 186. PubMed ID: 23260763
[TBL] [Abstract][Full Text] [Related]
55. Predictors for failure of Pneumocystis carinii pneumonia prophylaxis. Multicenter AIDS Cohort Study.
Saah AJ; Hoover DR; Peng Y; Phair JP; Visscher B; Kingsley LA; Schrager LK
JAMA; 1995 Apr; 273(15):1197-202. PubMed ID: 7707627
[TBL] [Abstract][Full Text] [Related]
56. Interhuman transmission as a potential key parameter for geographical variation in the prevalence of Pneumocystis jirovecii dihydropteroate synthase mutations.
Hauser PM; Nahimana A; Taffe P; Weber R; Francioli P; Bille J; Rabodonirina M
Clin Infect Dis; 2010 Aug; 51(4):e28-33. PubMed ID: 20604718
[TBL] [Abstract][Full Text] [Related]
57. High prevalence of dihydropteroate synthase mutations in Pneumocystis jirovecii isolated from patients with Pneumocystis pneumonia in South Africa.
Dini L; du Plessis M; Frean J; Fernandez V
J Clin Microbiol; 2010 Jun; 48(6):2016-21. PubMed ID: 20351205
[TBL] [Abstract][Full Text] [Related]
58. Failure of co-trimoxazole in Pneumocystis carinii infection and mutations in dihydropteroate synthase gene.
Mei Q; Gurunathan S; Masur H; Kovacs JA
Lancet; 1998 May; 351(9116):1631-2. PubMed ID: 9620722
[No Abstract] [Full Text] [Related]
59. [Diagnosis of pneumocystis carinii pneumonia in AIDS patients].
Armbruster C; Hassl A; Kriwanek S
Wien Klin Wochenschr; 1998 Sep; 110(17):604-7. PubMed ID: 9816629
[TBL] [Abstract][Full Text] [Related]
60. [Pneumocystis carinii pneumonia and HIV infection: diagnosis and treatment].
González-García J; Rubio García R; Antela López A; García Alcaide F
Enferm Infecc Microbiol Clin; 1998; 16 Suppl 1():36-44. PubMed ID: 9859618
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
